Your session is about to expire
← Back to Search
Intensive lifestyle intervention for Type 2 Diabetes (ILIAD Trial)
ILIAD Trial Summary
This trial is testing a new way to help people with Type 2 diabetes, by providing an intensive lifestyle intervention virtually. The study will last for 24 weeks and include 15 virtual visits.
- Type 2 Diabetes
ILIAD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ILIAD Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this trial accept individuals aged 45 and older as participants?
"This medical research accepts patients aged between 18 and 75, as those are the parameters outlined in its inclusion criteria."
Is this trial still recruiting participants?
"As indicated on clinicaltrials.gov, this medical experiment is still recruiting participants; the trial was initially posted in October of 2021 and recently updated in July of 2022."
How many volunteers are participating in this experiment?
"Affirmative. According to clinicaltrials.gov, this study first went live on October 14th 2021 and has since been updated in July 12th 2022. As of now, 16 patients from one medical centre are being sought after for the trial's recruitment process."
To whom is enrollment in this study open?
"This clinical trial requires 16 individuals with type 2 diabetes who are being treated with insulin and aged 18 to 75. Eligible applicants must meet the following requirements: Age between 18-75, BMI of 27 to 45kg/m2, diagnosed T2DM for at least 5 years, HbA1c under 9.5% in last 3 months, access to internet & telephone, stable dose of GLP-1 for 6 months minimum, good autonomy managing medications & meals preparation."
Share this study with friends
Copy Link
Messenger